3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
3
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
100
Carcinoma, Non-Small-Cell Lung
48
Neoplasms
34
Urinary Bladder Neoplasms
25
Lung Neoplasms
25
Cholangiocarcinoma
23
Breast Neoplasms
22
Neoplasm Metastasis
21
Ovarian Neoplasms
18
Lymphoma, Non-Hodgkin
13
Lymphoma
13
Recurrence
12
Lymphoma, Large B-Cell, Diffuse
11
Biliary Tract Neoplasms
11
Sarcoma
10
Carcinoma, Transitional Cell
9
Hodgkin Disease
8
Gallbladder Neoplasms
8
Fallopian Tube Neoplasms
8
Adenocarcinoma
8
Bile Duct Neoplasms
7
Colorectal Neoplasms
6
Triple Negative Breast Neoplasms
5
Lymphoma, Follicular
5
Liver Neoplasms
5
Head and Neck Neoplasms
5
Carcinoma, Renal Cell
5
Adenocarcinoma of Lung
5
Uterine Cervical Neoplasms
4
Small Cell Lung Carcinoma
4
Interventions
Sunitinib
2
pembrolizumab
1
palbociclib
1
linifanib
1
ixabepilone
1
VB6-845 fusion protein
1
Taxes
1
Sorafenib
1
Papanicolaou Test
1
Human Papillomavirus DNA Tests
1
Gemcitabine
1
Colposcopy
1
Cobicistat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Neoplasms, Glandular and Epithelial
×
Gemcitabine
×
Clear all
NCT05494866
2025-03-25
IntenSify
German Cancer Research Center
Phase 1
Terminated
6 enrolled